Lillys

Eli Lilly’s obesity drug beats rival in head-to-head trial – where Cramer sees stocks move next

[ad_1] New trial data has solidified the Club's lead position, holding off Eli Lilly in the highly competitive obesity drug…

5 months ago

FDA approves Eli Lilly’s weight-loss drug Zepbound for treatment of sleep apnea

[ad_1] An Eli Lilly & Co. Zepbound injector pen displayed in the Brooklyn borough of New York, United States, on…

5 months ago